Skip to content

The effects of peptide on mental health in adults: A randomized, double-blind, placebo-controlled study

The effects of peptide on mental health in adults: A randomized, double-blind, placebo-controlled study - The effects of peptide on mental health in adults: A randomized, double-blind, placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047487
Enrollment
140
Registered
2022-04-15
Start date
2022-04-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Ingestion of the test food for 4 weeks. Ingestion of the placebo food for 4 weeks.

Sponsors

Matsumoto City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 20-64 years old. 2) Subjects with mental health complaints.

Exclusion criteria

Exclusion criteria: 1) Subjects who use supplements, functional foods, or drugs associated with mental health. 2) Subjects with a history of and/or current mental illness or suspicion of mental illness. 3) Subjects who are undergoing medical treatment or have a previous medical history of serious diseases. 4) Subjects who have excessive alcoholic drinks (more than 60 g/day of alcohol). 5) Subjects who have severe drug allergy or severe food allergy, and/or a previous medical history of such allergies. 6) Subjects who participated in other clinical studies within 1 month before giving informed consent to participate in this study, or are planning to participate in other studies during this study. 7) Subjects who are pregnant or lactating, or who are expected to be pregnant during the study. 8) Subjects who are judged as ineligible to participate in this study by the principal investigator based on their background, physical findings, and so on.

Design outcomes

Primary

MeasureTime frame
Japanese version of POMS2

Secondary

MeasureTime frame
1) VAS (fatigue, stress, sleep) 2) STAI 3) Stress markers in saliva

Countries

Japan

Contacts

Public ContactKatsuya Furuhata

Matsumoto Health Lab None

info@m-health-lab.jp0263-39-1139

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026